Detection of elevated N ε-carboxymethyllysine levels in muscular tissue and in serum of patients with fibromyalgia

Scandinavian Journal of Rheumatology

Volumn 34, Issue 6, 2005, Pages 460-463

  Ruster M ^a,c   Franke, S ^a   Spath M ^b   Pongratz, D E ^b   Stein, G ^a   Hein, G E ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CD68 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 6; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROMYALGIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MONOCYTE; MUSCLE TISSUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TISSUE LEVEL;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CASE-CONTROL STUDIES; COLLAGEN; FEMALE; FIBROMYALGIA; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; LYSINE; MALE; MIDDLE AGED; MUSCLES; NF-KAPPA B; RECEPTORS, IMMUNOLOGIC;

EID: 30344482877     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740510026715     Document Type: Article

References (15)

1. Russell IJ. Neurochemical pathogenesis of fibromyalgia. Z Rheumatol 1998;57 Suppl 2: 63-6.
2. Lund N, Bengtsson A, Thorborg B. Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 1986;15:165-73.
3. Vlassara M, Bucala R, Striker L. Pathogenetic effects of advanced glucosylation: biochemical, biologic and clinical implications for diabetes and aging. Lab Invest 1994;70:138-51.
4. Ahmed MU, Thorpe SR, Baynes JW. Identification of N epsilon- carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 1986;261:4889-94.
5. Hein G, Franke S. Are advanced glycation end-product-modified proteins of pathogenetic importance in fibromyalgia? Rheumatology 2002;41:1163-7.
6. Franke S, Müller A, Sommer M, Busch M, Kientsch-Engel R, Stein G. Serum levels of total homocysteine, homocysteine metabolites and advanced glycation end-products (AGEs) in patients after renal transplantation. Clin Nephrol 2003;59:88-97.
7. Park J, Photimat P, Oates C, Hermanz-Schulman M, Olsen N. Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Arthritis Rheum 1998;41:406-13.
8. Jeschonneck M, Grohmann G, Hein G, Sprott H. Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia. Rheumatology 2000;39:917-21.
9. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001;108:949-55.
10. Hofmann MA, Schiekofer S, Isermann B, Kanitz M, Henkels M, Joswig M, et al. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy demonstrated increased activation of the oxidative-stress sensitive transcription NF-kB. Diabetologia 1999;42:222-32.
11. Sprott H, Müller A, Heine H. Collagen crosslinks in fibromyalgia. Arthritis Rheum 1997;40:1450-4.
12. Salemi S, Rethage J, Wollina U, Michel BA, Gay RE, Gay S, Sprott H. Detection of interleukin 1beta, IL-6 and tumor necrosis factor-alpha in skin of patients with fibromyalgia. J Rheumatol 2003;30:146-50.
13. Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M, et al. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 2004;114:1741-51.
14. Haslbeck KM, Bierhaus A, Erwin S, Kirchner A, Nawroth P, Schlotzer U, et al. Receptor for advanced glycation end-product (RAGE)-mediated nuclear factor-kappaB activation in vasculitic neuropathy. Muscle Nerve 2004;29:853-60.
15. Okamoto K, Martin DP, Schmelzer JD, Mitsui Y, Low PA. Pro- and antiinflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol 2001;169:386-91.